(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the Euronext session.
The three biggest winners today are CABKA EUR 13W, ABIONYX PHARMA, and DGB GROUP N.V..
| Financial Asset | Price | Change | Updated (EST) |
|---|---|---|---|
| CABKA EUR 13W (DSCW3.AS) | 0.02 | 42.86% | 2024-05-14 12:01:15 |
| ABIONYX PHARMA (ABNX.PA) | 1.17 | 13.18% | 2024-05-14 12:44:39 |
| DGB GROUP N.V. (DGB.AS) | 0.55 | 10% | 2024-05-14 12:01:35 |
| HYDROGENPRO (HYPRO.OL) | 10.36 | 9.98% | 2024-05-14 12:40:28 |
| NEL (NEL.OL) | 6.22 | 9.41% | 2024-05-14 12:41:21 |
| HOFSETH BIOCARE (HBC.OL) | 2.22 | 6.73% | 2024-05-14 12:40:26 |
| NORTHERN OCEAN LTD (NOL.OL) | 9.30 | 6.53% | 2024-05-14 12:41:37 |
| JUST EAT TAKEAWAY (TKWY.AS) | 14.23 | 5.68% | 2024-05-14 12:02:44 |
| CADELER (CADLR.OL) | 56.10 | 5.65% | 2024-05-14 12:25:22 |
| EQVA (EQVA.OL) | 3.79 | 5.16% | 2024-05-14 12:26:02 |
The three biggest losers today are VOW, PETRONOR E&P, and ENSURGE MICROPOWER.
| Financial Asset | Price | Change | Updated (EST) |
|---|---|---|---|
| VOW (VOW.OL) | 6.27 | -18.77% | 2024-05-14 12:44:14 |
| PETRONOR E&P (PNOR.OL) | 9.48 | -15.19% | 2024-05-14 12:42:12 |
| ENSURGE MICROPOWER (ENSU.OL) | 1.56 | -14.54% | 2024-05-14 12:25:56 |
| AGFA-GEVAERT (AGFB.BR) | 1.18 | -13.22% | 2024-05-14 12:04:52 |
| NYXOAH (NYXH.BR) | 8.18 | -8.71% | 2024-05-14 12:20:53 |
| RANA GRUBER (RANA.OL) | 75.70 | -8.56% | 2024-05-14 12:42:31 |
| BERGENBIO (BGBIO.OL) | 0.12 | -6.82% | 2024-05-14 12:24:57 |
| FUT.CLUBE PORTO (FCP.LS) | 1.40 | -6.67% | 2024-05-14 12:23:11 |
| SALMONES CAMANCHAC (SACAM.OL) | 23.20 | -5.69% | 2024-05-14 12:42:44 |
| ALMUNDA PRO NV (AMUND.AS) | 1.23 | -4.65% | 2024-05-14 12:00:26 |
Winners today
1. CABKA EUR 13W (DSCW3.AS)
42.86% Price Change
AEX-Index ended the session with CABKA EUR 13W jumping 42.86% to €0.02 on Tuesday while AEX-Index slid 0.14% to €910.63.
Yearly Top and Bottom Value
CABKA EUR 13W’s stock is valued at €0.02 at 22:40 EST, way higher than its 52-week high of €0.01.
More news about CABKA EUR 13W.
2. ABIONYX PHARMA (ABNX.PA)
13.18% Price Change
ABIONYX Pharma SA, a biotech company, discovers and develops therapies for the treatment of renal and ophthalmological diseases. It develops CER-001, a negatively-charged lipoprotein particle which contains human recombinant apoA-I, the natural high density lipoprotein (HDL) protein, and sphingomyelin and dipalmitoylphosphatidylglycerol natural phospholipids designed to mimicks the structural and functional biological properties of pre-beta HDL for the treatment of post-acute coronary syndrome patients and familial primary hypoalphalipoproteinemia patients; CER-002, a peroxisome proliferator-activated receptor delta specific agonist for the treatment of cardiovascular and metabolic diseases; and CER-209, a drug candidate for the treatment of metabolic diseases in the liver, as well as atherosclerois and non-alcoholic steato-hepatitis. The company was formerly known as Cerenis Therapeutics Holding SA and changed its name to ABIONYX Pharma SA in August 2019. ABIONYX Pharma SA was founded in 2005 and is based in Balma, France.
CAC 40 ended the session with ABIONYX PHARMA rising 13.18% to €1.17 on Tuesday while CAC 40 rose 0.2% to €8,225.80.
Earnings Per Share
As for profitability, ABIONYX PHARMA has a trailing twelve months EPS of €-0.12.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -58.11%.
Volatility
ABIONYX PHARMA’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.49%, a negative 0.44%, and a positive 1.80%.
ABIONYX PHARMA’s highest amplitude of average volatility was 1.47% (last week), 1.31% (last month), and 1.80% (last quarter).
Volume
Today’s last reported volume for ABIONYX PHARMA is 205260 which is 336.86% above its average volume of 46985.
Revenue Growth
Year-on-year quarterly revenue growth declined by 19.1%, now sitting on 4.75M for the twelve trailing months.
Yearly Top and Bottom Value
ABIONYX PHARMA’s stock is valued at €1.17 at 22:40 EST, way below its 52-week high of €2.38 and way higher than its 52-week low of €1.05.
More news about ABIONYX PHARMA.
3. DGB GROUP N.V. (DGB.AS)
10% Price Change
DGB Group N.V. invests in, develops, and manages carbon credits and biodiversity projects for businesses and governments in the Netherlands and internationally. The company offers nature-based solutions comprising removing or avoiding carbon emissions, tackling social, and environmental challenges; manages projects that focuses on ecosystem restoration, habitat conservation, and biodiversity enrichment; and undertakes plastic projects, which consists of removing and recycling plastic, waste reduction, and environmental conservation works, as well as carbon offsetting projects for reducing carbon footprint of companies. It also provides ESG reporting and tree integration services. The company was formerly known as Verenigde Nederlandse Compagnie N.V. and changed its name to DGB Group N.V. in January 2018. DGB Group N.V. was founded in 1957 and is based in Haarlemmermeer, the Netherlands.
AEX-Index ended the session with DGB GROUP N.V. jumping 10% to €0.55 on Tuesday, following the last session’s downward trend. AEX-Index dropped 0.14% to €910.63, after three successive sessions in a row of gains, on what was a somewhat bearish trend exchanging session today.
Earnings Per Share
As for profitability, DGB GROUP N.V. has a trailing twelve months EPS of €-0.15.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -8.73%.
Volume
Today’s last reported volume for DGB GROUP N.V. is 73456 which is 794.27% above its average volume of 8214.
More news about DGB GROUP N.V..
4. HYDROGENPRO (HYPRO.OL)
9.98% Price Change
HydrogenPro ASA engages in designing and delivering hydrogen technology and systems in Norway, Europe, the United States, and the Asia Pacific. It offers high-pressure alkaline electrolyzers. The company serves synthetic aviation fuel, refinery/decarbonization, power to gas, balancing the grid, steel production, fertilizer/ammonia, and shipping markets. HydrogenPro ASA was incorporated in 2013 and is headquartered in Porsgrunn, Norway.
Oslo Børs Benchmark Index_GI ended the session with HYDROGENPRO jumping 9.98% to €10.36 on Tuesday, after two sequential sessions in a row of losses. Oslo Børs Benchmark Index_GI rose 0.04% to €1,417.00, following the last session’s downward trend on what was a somewhat up trend trading session today.
Earnings Per Share
As for profitability, HYDROGENPRO has a trailing twelve months EPS of kr-1.48.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -23.59%.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is a negative 300% and a negative 25%, respectively.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, HYDROGENPRO’s stock is considered to be overbought (>=80).
Volatility
HYDROGENPRO’s last week, last month’s, and last quarter’s current intraday variation average was a negative 2.96%, a negative 2.15%, and a positive 4.32%.
HYDROGENPRO’s highest amplitude of average volatility was 4.52% (last week), 4.26% (last month), and 4.32% (last quarter).
More news about HYDROGENPRO.
5. NEL (NEL.OL)
9.41% Price Change
Nel ASA, a hydrogen company, provides various solutions to produce, store, and distribute hydrogen from renewable energy in Norway and internationally. The company operates in two segments, Nel Hydrogen Fueling and Nel Hydrogen Electrolyser. The Nel Hydrogen Fueling segment manufactures hydrogen fueling stations for fuel cell electric vehicles, such as cars, buses, trucks, and other on-road vehicles. The Nel Hydrogen Electrolyser segment supplies hydrogen production equipment based on alkaline and proton exchange membrane water electrolysis technology. It serves industries, energy, and gas companies. The company was formerly known as DiaGenic ASA and changed its name to Nel ASA in October 2014. Nel ASA was founded in 1927 and is headquartered in Oslo, Norway.
Oslo Børs Benchmark Index_GI ended the session with NEL rising 9.41% to €6.22 on Tuesday, following the last session’s downward trend. Oslo Børs Benchmark Index_GI rose 0.04% to €1,417.00, following the last session’s downward trend on what was a somewhat bullish trend exchanging session today.
Earnings Per Share
As for profitability, NEL has a trailing twelve months EPS of kr-0.41.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -10.47%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 14%, now sitting on 1.73B for the twelve trailing months.
Volatility
NEL’s last week, last month’s, and last quarter’s current intraday variation average was 0.45%, 0.36%, and 3.06%.
NEL’s highest amplitude of average volatility was 4.31% (last week), 3.13% (last month), and 3.06% (last quarter).
More news about NEL.
6. HOFSETH BIOCARE (HBC.OL)
6.73% Price Change
Hofseth BioCare ASA operates as a consumer and pet health ingredient supplier and incubator in Norway, the United Kingdom, France, Belgium, Europe, Japan, Asia, and the United States. The company's products include OmeGo, a salmon oil, which offers the full spectrum of fatty acids and omegas found naturally in fresh whole salmon; ProGo, a bioactive peptide for VMS, metabolism and active nutrition needs; CalGo, an absorbable complex mineral for bone and joint health; CollaGo; and PetGo, a non-soluble protein. Hofseth BioCare ASA was incorporated in 2000 and is headquartered in Ålesund, Norway.
Oslo Børs Benchmark Index_GI ended the session with HOFSETH BIOCARE jumping 6.73% to €2.22 on Tuesday while Oslo Børs Benchmark Index_GI jumped 0.04% to €1,417.00.
Earnings Per Share
As for profitability, HOFSETH BIOCARE has a trailing twelve months EPS of kr-0.27.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -112.79%.
More news about HOFSETH BIOCARE.
7. NORTHERN OCEAN LTD (NOL.OL)
6.53% Price Change
Northern Ocean Ltd., a drilling contractor, provides offshore contract drilling services for the oil and gas industry worldwide. The company owns two semi-submersible rigs. It also invests in battery systems and power generation solutions. Northern Ocean Ltd. was incorporated in 2017 and is based in Hamilton, Bermuda.
Oslo Børs Benchmark Index_GI ended the session with NORTHERN OCEAN LTD jumping 6.53% to €9.30 on Tuesday, after two successive sessions in a row of gains. Oslo Børs Benchmark Index_GI jumped 0.04% to €1,417.00, following the last session’s downward trend on what was a somewhat positive trend trading session today.
Earnings Per Share
As for profitability, NORTHERN OCEAN LTD has a trailing twelve months EPS of kr-4.37.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -15.03%.
Sales Growth
NORTHERN OCEAN LTD’s sales growth is 135.5% for the current quarter and 127.4% for the next.
Revenue Growth
Year-on-year quarterly revenue growth grew by 606%, now sitting on 217.02M for the twelve trailing months.
Volume
Today’s last reported volume for NORTHERN OCEAN LTD is 226054 which is 60.49% above its average volume of 140847.
More news about NORTHERN OCEAN LTD.
8. JUST EAT TAKEAWAY (TKWY.AS)
5.68% Price Change
Just Eat Takeaway.com N.V. operates as an online food delivery company worldwide. Its marketplace connects consumers and restaurants through its platforms. The company was founded in 2000 and is headquartered in Amsterdam, the Netherlands.
AEX-Index ended the session with JUST EAT TAKEAWAY jumping 5.68% to €14.23 on Tuesday while AEX-Index slid 0.14% to €910.63.
Earnings Per Share
As for profitability, JUST EAT TAKEAWAY has a trailing twelve months EPS of €-8.69.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -26.5%.
Moving Average
JUST EAT TAKEAWAY’s value is above its 50-day moving average of €13.88 and higher than its 200-day moving average of €13.58.
Yearly Top and Bottom Value
JUST EAT TAKEAWAY’s stock is valued at €14.23 at 22:40 EST, way below its 52-week high of €17.66 and way above its 52-week low of €10.19.
More news about JUST EAT TAKEAWAY.
9. CADELER (CADLR.OL)
5.65% Price Change
Cadeler A/S operates as an offshore wind farm transportation and installation contractor in Denmark. It also provides wind farm construction, maintenance, decommissioning, and other tasks within the offshore industry, as well as marine and engineering services. The company owns and operates four offshore jack-up windfarm installation vessels. Cadeler A/S was incorporated in 2008 and is headquartered in Copenhagen, Denmark.
Oslo Børs Benchmark Index_GI ended the session with CADELER rising 5.65% to €56.10 on Tuesday while Oslo Børs Benchmark Index_GI rose 0.04% to €1,417.00.
Earnings Per Share
As for profitability, CADELER has a trailing twelve months EPS of kr0.7.
PE Ratio
CADELER has a trailing twelve months price to earnings ratio of 80.14. Meaning, the purchaser of the share is investing kr80.14 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.21%.
Volume
Today’s last reported volume for CADELER is 369530 which is 68.78% below its average volume of 1183830.
Volatility
CADELER’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.78%, a positive 0.20%, and a positive 1.80%.
CADELER’s highest amplitude of average volatility was 1.78% (last week), 1.89% (last month), and 1.80% (last quarter).
Revenue Growth
Year-on-year quarterly revenue growth grew by 121.3%, now sitting on 106.42M for the twelve trailing months.
More news about CADELER.
10. EQVA (EQVA.OL)
5.16% Price Change
Eqva ASA, provides technical solutions and services to maritime and land based industries in Norway and internationally. It operates in three segments: Products, Solutions & Renewables; Real Estate; and Other. The company provides technical installations to the land-based and maritime industry; and develops and operates small-scale hydropower plants. It also engages in real estate business. The company was formerly known as Havyard Group ASA and changed its name to Eqva ASA in November 2022. Eqva ASA was incorporated in 1999 and is headquartered in Kvinnherad, Norway.
Oslo Børs Benchmark Index_GI ended the session with EQVA rising 5.16% to €3.79 on Tuesday, following the last session’s upward trend. Oslo Børs Benchmark Index_GI rose 0.04% to €1,417.00, following the last session’s downward trend on what was a somewhat positive trend trading session today.
Earnings Per Share
As for profitability, EQVA has a trailing twelve months EPS of kr-0.33.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -5.45%.
Volatility
EQVA’s last week, last month’s, and last quarter’s current intraday variation average was 1.59%, 0.23%, and 2.37%.
EQVA’s highest amplitude of average volatility was 2.16% (last week), 2.67% (last month), and 2.37% (last quarter).
More news about EQVA.
Losers Today
1. VOW (VOW.OL)
-18.77% Price Change
Vow ASA, together with its subsidiaries, produces, delivers, and maintains systems for processing and purifying wastewater, food waste, solid waste, and bio sludge in Norway, France, Poland, the United States, and Italy. It operates in three segments: Projects Cruise, Aftersales, and Landbased. The Projects Cruise segment delivers ship systems to shipyards for newbuild constructions, which include advanced wastewater purification, waste management, and food waste processing; and advanced systems to shipowners for ships. The Aftersales segment provides spare parts and consumables; chemicals; and tailor-made service and maintenance programs. The Landbased segment offers Biogreen, a patented pyrolysis process for converting biomass, plastics, and waste into energy; Safesteril, a patented sterilisation process for food and pharmaceutical ingredients; and industrial robotics solutions, including robotic systems for waste recycling processes. This segment also develops, designs, and fabricates industrial furnaces and equipment for heat treatment processes. The company serves cruise, aquaculture, and landbased industries, as well as utilities. It has a strategic partnership agreement with Repsol, S.A. to explore applications and solutions to produce clean and renewable energy for CO2 emission reduction; European Tyre Enterprise Ltd. to develop a modularised and industrial solutions, and value chain to turn end-of-life tires into raw material and renewable energy; GRTgaz to produce a demo plant built to confirm that CO2 neutral pyrolysis gas can replace fossil gas in the European gas grid; SAS IMPROVE to develop technological solutions for the farm to fork valorisation of future proteins; and Imtech Steri's Biosteam to offer a range of ingredient sterilisation solutions and services. The company was formerly known as Scanship Holding ASA and changed its name to VOW ASA in January 2020. Vow ASA was founded in 2011 and is headquartered in Lysaker, Norway.
Oslo Børs Benchmark Index_GI ended the session with VOW sliding 18.77% to €6.27 on Tuesday while Oslo Børs Benchmark Index_GI jumped 0.04% to €1,417.00.
Earnings Per Share
As for profitability, VOW has a trailing twelve months EPS of kr-1.34.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -33.1%.
More news about VOW.
2. PETRONOR E&P (PNOR.OL)
-15.19% Price Change
PetroNor E&P ASA operates as an independent oil and gas exploration and production company in countries offshore West Africa. The company holds exploration and production assets, which includes the PNGF Sud licenses in Congo Brazzaville, the A4 license in The Gambia, the Sinapa (Block 2) and Esperança (Blocks 4A and 5A) licenses in Guinea-Bissau, the Rufisque Offshore Profond and Senegal Offshore Sud Profond in Senegal, and OML-113 in Nigeria. PetroNor E&P ASA was founded in 2017 and is headquartered in Oslo, Norway.
Oslo Børs Benchmark Index_GI ended the session with PETRONOR E&P falling 15.19% to €9.48 on Tuesday while Oslo Børs Benchmark Index_GI rose 0.04% to €1,417.00.
Earnings Per Share
As for profitability, PETRONOR E&P has a trailing twelve months EPS of kr3.92.
PE Ratio
PETRONOR E&P has a trailing twelve months price to earnings ratio of 2.42. Meaning, the purchaser of the share is investing kr2.42 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 41.19%.
Volatility
PETRONOR E&P’s last week, last month’s, and last quarter’s current intraday variation average was 2.77%, 1.39%, and 1.65%.
PETRONOR E&P’s highest amplitude of average volatility was 4.32% (last week), 2.65% (last month), and 1.65% (last quarter).
More news about PETRONOR E&P.
3. ENSURGE MICROPOWER (ENSU.OL)
-14.54% Price Change
Ensurge Micropower ASA manufactures and sells ultrathin energy storage solutions for wearable devices, connected sensors, and other applications. Its solid-state lithium battery technology enables it to produce rechargeable batteries. The company was formerly known as Thin Film Electronics ASA and changed its name to Ensurge Micropower ASA in June 2021. Ensurge Micropower ASA was incorporated in 2005 and is headquartered in Oslo, Norway.
Oslo Børs Benchmark Index_GI ended the session with ENSURGE MICROPOWER falling 14.54% to €1.56 on Tuesday while Oslo Børs Benchmark Index_GI rose 0.04% to €1,417.00.
Earnings Per Share
As for profitability, ENSURGE MICROPOWER has a trailing twelve months EPS of kr-3.92.
Yearly Top and Bottom Value
ENSURGE MICROPOWER’s stock is valued at kr1.56 at 22:40 EST, way under its 52-week high of kr4.19 and way higher than its 52-week low of kr0.10.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, ENSURGE MICROPOWER’s stock is considered to be overbought (>=80).
Volume
Today’s last reported volume for ENSURGE MICROPOWER is 79769700 which is 306.02% above its average volume of 19646400.
More news about ENSURGE MICROPOWER.
4. AGFA-GEVAERT (AGFB.BR)
-13.22% Price Change
Agfa-Gevaert NV develops, produces, and distributes various analog and digital imaging systems worldwide. It operates through four segments: HealthCare IT, Digital Print & Chemicals, Radiology Solutions, and CONOPS. The company's CONOPS segment engages in supply of film and chemicals, as well support services. Its Radiology Solutions segment offers analog and digital imaging technology for diagnostic imaging market to meet the needs of specialized clinicians in hospitals and imaging centers; and X-ray film, hardcopy film and printers, digital radiography equipment, and image processing software. The company's Healthcare IT segment provides healthcare's enterprise imaging platform. Its Digital Print & Chemicals segment offers inkjet printers for sign and display and packaging printing companies; inkjet inks and fluids for industrial inkjet applications, such as signs, posters and displays, promotional materials, packaging, leather goods, laminated flooring, and decorative materials, as well as for printed electronics industry; electrolysis membranes to the hydrogen production industry, as well as for printable synthetic papers. This segment also provides films for micrography, non-destructive testing, aerial photography and printed circuit board production; membranes for green hydrogen production; and conductive polymers and materials for the production of high-security ID documents. The company sells its products through its own sales organization, as well as through a network of agents and representatives. Agfa-Gevaert NV was founded in 1867 and is headquartered in Mortsel, Belgium.
BEL 20 ended the session with AGFA-GEVAERT dropping 13.22% to €1.18 on Tuesday while BEL 20 slid 0.3% to €3,968.81.
Earnings Per Share
As for profitability, AGFA-GEVAERT has a trailing twelve months EPS of €-1.34.
Volatility
AGFA-GEVAERT’s last week, last month’s, and last quarter’s current intraday variation average was 1.34%, 0.57%, and 2.68%.
AGFA-GEVAERT’s highest amplitude of average volatility was 1.65% (last week), 1.75% (last month), and 2.68% (last quarter).
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, AGFA-GEVAERT’s stock is considered to be oversold (<=20).
Volume
Today’s last reported volume for AGFA-GEVAERT is 1277110 which is 252.57% above its average volume of 362223.
More news about AGFA-GEVAERT.
5. NYXOAH (NYXH.BR)
-8.71% Price Change
Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company's lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
BEL 20 ended the session with NYXOAH sliding 8.71% to €8.18 on Tuesday while BEL 20 slid 0.3% to €3,968.81.
Earnings Per Share
As for profitability, NYXOAH has a trailing twelve months EPS of €-1.54.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -39.58%.
More news about NYXOAH.
6. RANA GRUBER (RANA.OL)
-8.56% Price Change
Rana Gruber ASA engages in the mining, processing, and sale of iron ore concentrate. The company excavates, processes, and sells iron oxide in the form of hematite that is used for metallurgical applications; magnetite to produce water treatment chemicals; and other special products, such as iron oxide pigments that is used for colorants and developed products under the Colorana brand name. It markets its products to steel manufacturers, water treatment chemical producers, as well as concrete, paint, plastics, heat management, automotive, and toner production industry sectors. The company also exports its products mainly to European customers. Rana Gruber ASA was founded in 1937 and is headquartered in Mo i Rana, Norway.
Oslo Børs Benchmark Index_GI ended the session with RANA GRUBER dropping 8.56% to €75.70 on Tuesday, following the last session’s downward trend. Oslo Børs Benchmark Index_GI jumped 0.04% to €1,417.00, following the last session’s downward trend on what was a somewhat bullish trend trading session today.
Earnings Per Share
As for profitability, RANA GRUBER has a trailing twelve months EPS of kr13.21.
PE Ratio
RANA GRUBER has a trailing twelve months price to earnings ratio of 5.73. Meaning, the purchaser of the share is investing kr5.73 for every norwegian krone of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 56.79%.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Feb 19, 2024, the estimated forward annual dividend rate is 17.08 and the estimated forward annual dividend yield is 20.83%.
More news about RANA GRUBER.
7. BERGENBIO (BGBIO.OL)
-6.82% Price Change
BerGenBio ASA, a clinical-stage biopharmaceutical company, engages in development of novel medicines to treat immune-evasive, drug resistant, and metastatic cancers; and respiratory diseases. It develops bemcentinib, an oral once-a-day inhibitor of AXL receptor tyrosine kinase, which is in Phase 1b/2a clinical trial to treat non-small cell lung cancer, and Phase 2 clinical trial to treat acute myeloid leukemia and COVID-19. Bemcentinib is also being studied for glioblastoma, 2L lung cancer, melanoma, pancreatic cancer, and mesothelioma. In addition, the company is developing tilvestamab, an anti-AXL function-blocking monoclonal antibody that is in Phase 1b clinical trial for the treatment of ovarian cancer; and mipasetamab uzoptirine, which is in Phase 1 clinical trial for the treatment of solid tumors. It has a collaboration agreement with Merck & Co. for clinical trials. The company was incorporated in 2007 and is based in Bergen, Norway.
Oslo Børs Benchmark Index_GI ended the session with BERGENBIO sliding 6.82% to €0.12 on Tuesday, following the last session’s downward trend. Oslo Børs Benchmark Index_GI rose 0.04% to €1,417.00, following the last session’s downward trend on what was a somewhat up trend exchanging session today.
Earnings Per Share
As for profitability, BERGENBIO has a trailing twelve months EPS of kr-0.13.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -179.58%.
Volume
Today’s last reported volume for BERGENBIO is 75702500 which is 72.37% above its average volume of 43916100.
More news about BERGENBIO.
8. FUT.CLUBE PORTO (FCP.LS)
-6.67% Price Change
Futebol Clube do Porto – Futebol, S.A.D., together with its subsidiaries, participates in professional football competitions, and the sporting events promotion and organization in Portugal. It also engages in the image rights commercialization, sponsoring, merchandising, and products licensing activities; production, editing, and commercialization of multimedia material, as well as Internet, periodical, and non-periodical publications; and sport equipment management and exploration business, as well as insurance broking activities. In addition, the company organizes and sells travel and tour packages; and tickets and seat reservations, as well as represents travel agencies and tourism. Further, it is involved in the concept, design, development, production, direction, promotion, marketing, acquisition, exploration rights, recording, distribution, and dissemination of works and audiovisual programs, multimedia, television, video, cinema, theme, Internet, channels, tourist events, and cultural and sporting in any formats and systems. Additionally, the company manages, operates, and provides services in the areas of recording, production, and communication of audiovisual works, television shows, sounds, images, and other audiovisuals; and edits periodic publicities, books, and multimedia. It also explores for the Porto Canal cable television channel; and produces and executes advertisings, news reports, documentaries, and TV programs in video support. The company was founded in 1893 and is headquartered in Porto, Portugal.
PSI ended the session with FUT.CLUBE PORTO sliding 6.67% to €1.40 on Tuesday, following the last session’s downward trend. PSI jumped 0.69% to €6,919.54, following the last session’s downward trend on what was a somewhat bullish trend trading session today.
Earnings Per Share
As for profitability, FUT.CLUBE PORTO has a trailing twelve months EPS of €-2.12.
Volume
Today’s last reported volume for FUT.CLUBE PORTO is 1318 which is 251.46% above its average volume of 375.
Moving Average
FUT.CLUBE PORTO’s worth is way above its 50-day moving average of €1.19 and way above its 200-day moving average of €1.16.
Volatility
FUT.CLUBE PORTO’s last week, last month’s, and last quarter’s current intraday variation average was 2.25%, 2.20%, and 5.23%.
FUT.CLUBE PORTO’s highest amplitude of average volatility was 11.14% (last week), 4.74% (last month), and 5.23% (last quarter).
Yearly Top and Bottom Value
FUT.CLUBE PORTO’s stock is valued at €1.40 at 22:40 EST, higher than its 52-week high of €1.30.
More news about FUT.CLUBE PORTO.
9. SALMONES CAMANCHAC (SACAM.OL)
-5.69% Price Change
Salmones Camanchaca S.A. engages in the salmon farming business in Chile. The company offers Atlantic and Coho salmon products in various formats, such as whole, fillet, portion, and other products including bits and pieces, harasu, and scrape meat. It also exports its products. The company was incorporated in 2009 and is based in Puerto Montt, Chile. Salmones Camanchaca S.A. is a subsidiary of Compañía Pesquera Camanchaca S.A.
Oslo Børs Benchmark Index_GI ended the session with SALMONES CAMANCHAC falling 5.69% to €23.20 on Tuesday, after two consecutive sessions in a row of losses. Oslo Børs Benchmark Index_GI rose 0.04% to €1,417.00, following the last session’s downward trend on what was a somewhat up trend trading session today.
Earnings Per Share
As for profitability, SALMONES CAMANCHAC has a trailing twelve months EPS of kr-0.91.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -2.94%.
Yearly Top and Bottom Value
SALMONES CAMANCHAC’s stock is valued at kr23.20 at 22:40 EST, way under its 52-week high of kr47.80 and way higher than its 52-week low of kr21.00.
Revenue Growth
Year-on-year quarterly revenue growth declined by 4%, now sitting on 353.91M for the twelve trailing months.
Moving Average
SALMONES CAMANCHAC’s value is below its 50-day moving average of kr23.94 and way below its 200-day moving average of kr31.61.
More news about SALMONES CAMANCHAC.
10. ALMUNDA PRO NV (AMUND.AS)
-4.65% Price Change
Almunda Professionals N.V., a business and IT consultancy company, provides business services in the financial sector. It offers consultancy services in the areas of regulatory change, digital transformation, information security, and information services. The company was formerly known as Novisource N.V. and changed its name to Almunda Professionals N.V. in August 2021. Almunda Professionals N.V. was founded in 2001 and is based in Amsterdam, the Netherlands.
AEX-Index ended the session with ALMUNDA PRO NV dropping 4.65% to €1.23 on Tuesday, after five successive sessions in a row of losses. AEX-Index slid 0.14% to €910.63, after three consecutive sessions in a row of gains, on what was a somewhat down trend trading session today.
Earnings Per Share
As for profitability, ALMUNDA PRO NV has a trailing twelve months EPS of €0.02.
PE Ratio
ALMUNDA PRO NV has a trailing twelve months price to earnings ratio of 61.5. Meaning, the purchaser of the share is investing €61.5 for every euro of annual earnings.
Return on Equity
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -4.64%.
More news about ALMUNDA PRO NV.
Stay up to date with our winners and losers daily report
